Literature DB >> 18166360

Chemoprevention for colorectal cancer: some progress but a long way to go.

Peter Lance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18166360     DOI: 10.1053/j.gastro.2007.11.024

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.

Authors:  Christine Cole Johnson; Richard B Hayes; Robert E Schoen; Marc J Gunter; Wen-Yi Huang
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

2.  Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.

Authors:  Patricia Thompson; Denise J Roe; Liane Fales; Julie Buckmeier; Fang Wang; Stanley R Hamilton; Achyut Bhattacharyya; Sylvan Green; Chiu-Hsieh Hsu; H-H Sherry Chow; Dennis J Ahnen; C Richard Boland; Russell I Heigh; David E Fay; Maria Elena Martinez; Elizabeth Jacobs; Erin L Ashbeck; David S Alberts; Peter Lance
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-11

Review 3.  Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer.

Authors:  Nathaniel S Rial; Jason A Zell; Alfred M Cohen; Eugene W Gerner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-08       Impact factor: 3.869

4.  Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice.

Authors:  Peter Lance; Patricia A Thompson
Journal:  J Carcinog       Date:  2011-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.